Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia

Reductase Inhibitor ◽

Term Treatment ◽

Hmg Coa Reductase ◽

Long Term Treatment ◽

Long-term effects of NK-104 (itavastatin), a new HMG-CoA reductase inhibitor, in patients with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(00)80237-3 ◽

2000 ◽

Vol 151 (1) ◽

pp. 53 ◽

Cited By ~ 3

Author(s):

H Mabuchi

Keyword(s):

Reductase Inhibitor ◽

Long Term Effects ◽

Hmg Coa Reductase ◽

Clinical efficacy of fluvastatin, a new synthetic HMG-CoA reductase inhibitor, in long-term treatment of hyperlipidemia; results of a multicenter long-term study

Atherosclerosis ◽

10.1016/0021-9150(94)93674-9 ◽

1994 ◽

Vol 109 (1-2) ◽

pp. 166

Author(s):

T. Teramoto ◽

Y. Goto

Keyword(s):

Clinical Efficacy ◽

Reductase Inhibitor ◽

Term Treatment ◽

Term Study ◽

Hmg Coa Reductase ◽

Long Term Study ◽

Long Term Treatment ◽

Additive effects of another kind of HMG-CoA reductase inhibitor with different pharmacokinetics in the treatment of heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(00)00626-2 ◽

2000 ◽

Vol 153 (2) ◽

pp. 525-526 ◽

Cited By ~ 1

Author(s):

Tsuyoshi Nozue ◽

Atsushi Nohara ◽

Toshinori Higashikata ◽

Akihiro Inazu ◽

Hiroshi Mabuchi ◽

...

Keyword(s):

Reductase Inhibitor ◽

Additive Effects ◽

Hmg Coa Reductase ◽

High density lipoprotein cholesterol and apolipoprotein A-I are persistently elevated during long-term treatment with pitavastatin, a new HMG-CoA reductase inhibitor

International Journal of Cardiology ◽

10.1016/j.ijcard.2008.11.130 ◽

2010 ◽

Vol 141 (3) ◽

pp. 320-322 ◽

Cited By ~ 12

Author(s):

Tatsuya Fukutomi ◽

Yutaka Takeda ◽

Shogo Suzuki ◽

Tatsuya Ito ◽

Takashi Joh ◽

...

Keyword(s):

High Density Lipoprotein ◽

High Density Lipoprotein Cholesterol ◽

Reductase Inhibitor ◽

Density Lipoprotein ◽

Term Treatment ◽

Apolipoprotein A ◽

Long Term Treatment ◽

1P-0091 Long-term combination therapy with an HMG-COA reductase inhibitor, pravastatin, and an ACE inhibitor, captopril, seems to be beneficial for hypercholesterolemic hypertensives

Atherosclerosis Supplements ◽

10.1016/s1567-5688(03)90166-8 ◽

2003 ◽

Vol 4 (2) ◽

pp. 39

Author(s):

H. Shionoiri ◽

I. Takasaki ◽

F. Shionoiri

Keyword(s):

Combination Therapy ◽

Reductase Inhibitor ◽

Ace Inhibitor ◽

Hmg Coa Reductase ◽

Long-Term Treatment (2 Years) with the HMG CoA Reductase Inhibitors Lovastatin or Pravastatin in Combination with Cholestyramine in Patients with Severe Primary Hypercholesterolemia

Journal of Cardiovascular Pharmacology ◽

10.1097/00005344-199309000-00008 ◽

1993 ◽

Vol 22 (3) ◽

pp. 396-400

Author(s):

Bernd G. Jacob ◽

Werner O. Richter ◽

Peter Schwandt

Keyword(s):

Term Treatment ◽

Hmg Coa Reductase ◽

Primary Hypercholesterolemia ◽

Reductase Inhibitors ◽

Long Term Treatment ◽

Hmg Coa Reductase Inhibitors ◽

Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia

Atherosclerosis ◽

10.1016/s0021-9150(02)00005-9 ◽

2002 ◽

Vol 163 (1) ◽

pp. 205-206 ◽

Cited By ~ 16

Author(s):

Vasilios G. Athyros ◽

Athanasios A. Papageorgiou ◽

Athanasios G. Kontopoulos

Keyword(s):

Term Treatment ◽

Adolescent Males ◽

Long Term Treatment

A long-term comparative trial of cerivastatin sodium, a new HMG-CoA reductase inhibitor, in patients with primary hypercholesterolemia

Clinical Therapeutics ◽

10.1016/s0149-2918(98)80063-5 ◽

1998 ◽

Vol 20 (3) ◽

pp. 539-548 ◽

Cited By ~ 4

Author(s):

Jun Sasaki ◽

Kikuo Arakawa ◽

Kyosuke Yamamoto ◽

Shozo Kobori ◽

Masato Ageta ◽

...

Keyword(s):

Reductase Inhibitor ◽

Comparative Trial ◽

Hmg Coa Reductase ◽

Primary Hypercholesterolemia ◽

The Effects of Long Term Use of HMG-CoA Reductase Inhibitor on the Level of Lp (a)

Korean Circulation Journal ◽

10.4070/kcj.1999.29.12.1350 ◽

1999 ◽

Vol 29 (12) ◽

pp. 1350

Author(s):

Jin Won Kim ◽

Hong Seog Seo ◽

Sung Hee Sin ◽

Yung Jae Oh ◽

Jung Chun Ahn ◽

...

Keyword(s):

Reductase Inhibitor ◽

Hmg Coa Reductase ◽

Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

European Journal of Clinical Pharmacology ◽

10.1007/bf00194398 ◽

1994 ◽

Vol 46 (4) ◽

Cited By ~ 56

Author(s):

R. Laaksonen ◽

J.-P. Ojala ◽

M.J. Tikkanen ◽

J.-J. Himberg

Keyword(s):

Term Treatment ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Long Term Treatment ◽

Hmg Coa Reductase Inhibitors ◽

Short And Long Term ◽